Thermoformed Medical Packaging Market Report 2026

The thermoformed medical packaging market size has grown strongly in recent years. It will grow from $24.42 billion in 2025 to $25.89 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to growing pharmaceutical production, increasing medical device usage, rising regulatory compliance for packaging, adoption of PETG and APET materials, expansion of healthcare infrastructure.

The thermoformed medical packaging market size is expected to see strong growth in the next few years. It will grow to $32.97 billion by 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing demand for personalized medical packaging, rising adoption of biodegradable and sustainable materials, growing use of automation in thermoforming processes, expansion of sterile packaging for vaccines and injectables, increasing requirement for packaging traceability and serialization. Major trends in the forecast period include increasing demand for sterile and tamper-proof packaging, rising adoption of custom thermoformed trays and clamshells, growing use of high-barrier materials for pharmaceutical protection, expansion of single-use medical packaging solutions, rising focus on cost-effective packaging for drug delivery.

The growing adoption of disposable medical products is projected to propel the growth of the thermoformed medical packaging market in the coming years. Disposable medical products include single-use medical items such as syringes, catheters, surgical trays, surgical gowns, diagnostic kits, and protective equipment, which are designed for one-time use to prevent contamination and infection. The rising adoption of disposable medical products is driven by increasing concerns over infection control, as these products help minimize cross-contamination and enhance patient safety. Thermoformed medical packaging supports disposable medical products by providing sterile, durable, and precisely molded protective solutions that ensure safety, extend shelf life, and maintain product integrity during storage and transportation. For instance, in February 2026, according to the Government Commercial Function, a UK-based government agency, clinical teams at Barts Health NHS Trust are projected to utilize approximately 400,000 gowns annually across their theaters. Therefore, the increasing adoption of disposable medical products is contributing to the growth of the thermoformed medical packaging market.

Leading companies operating in the thermoformed medical packaging market are focusing on technological advancements such as amorphous polyethylene terephthalate (APET)-based material to enhance packaging clarity, strength, sterilization compatibility, and sustainability while improving manufacturing efficiency. An amorphous polyethylene terephthalate (APET)-based formulation refers to a type of polyethylene terephthalate plastic in which the polymer chains are arranged in a non-crystalline (amorphous) structure by giving it high transparency and good mechanical strength. For example, in October 2025, Amcor plc., a Switzerland-based packaging company, launches AmSecure, a next-generation thermoformed medical and pharmaceutical packaging solution based on amorphous polyethylene terephthalate (APET). This solution offers high clarity, strong mechanical performance, and compatibility with standard sterilization processes, while supporting multiple raw material sourcing options to enhance supply chain reliability and meet recyclability requirements. It provides healthcare manufacturers with a cost-effective and sustainable packaging platform. It is available in pre-formed trays and roll stock formats that are compatible with various lids and pouches, enabling flexible packaging configurations for medical devices and pharmaceutical products while ensuring sterility, convenience, and ease of use during storage and clinical application.

In December 2025, Nelipak Corporation, a US-based healthcare and medical packaging solutions company, acquired Merrill’s Packaging Inc. for an undisclosed amount. Through this acquisition, Nelipak aims to propel the expansion of its global footprint in medical and pharmaceutical packaging by integrating Merrill’s expertise in custom thermoformed solutions, including sterile barrier trays and blisters designed for medical devices and pharmaceuticals, thereby contributing to and supporting the enhancement of its capabilities in high-quality, regulatory-compliant healthcare packaging. Merrill’s Packaging Inc. is a US-based medical packaging company specializing in custom thermoformed solutions for medical devices, pharmaceuticals, and life sciences.

Major companies operating in the thermoformed medical packaging market are Amcor plc, TOPPAN Holdings, Klockner Pentaplast Group, Constantia Flexibles Group GmbH, Gerresheimer AG, Winpak Ltd., Inteplast Group Corporation, Prent Corporation, Nelipak Corporation, Placon Corporation, Plastic Ingenuity Inc., Brentwood Industries Inc., Display Pack Inc., TO Plastics Inc., Dordan Manufacturing Company, Dordan Manufacturing Company Inc., Tru‑Form Plastics Inc., GY Packaging USA Inc., Abon Plastic S.r.l., TekPak Solutions Inc.

North America was the largest region in the thermoformed medical packaging market in 2025. Asis-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thermoformed medical packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thermoformed medical packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thermoformed medical packaging market consists of sales of sterile barrier packaging, surgical instrument packaging trays, medical device protective inserts, syringe and needle protective holders, and catheter packaging trays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.